| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $14.2M | +6.7% | +7.2% |
| R&D Expense | $792K | +1.0% | +10.9% |
| Operating Income | $2.5M | +38.3% | -12.7% |
| Pre-tax Income | $2.8M | +38.5% | -8.1% |
| Income Tax | $931K | +114.0% | +25.6% |
| Net Income | $1.8M | +17.4% | -19.2% |
| EPS (Basic) | $0.64 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $18.3M | +18.0% | +115.9% |
| Accounts Receivable | $6.2M | -0.5% | +2.8% |
| Inventory | $9.3M | +1.7% | -2.9% |
| Current Assets | $34.9M | +9.9% | +41.6% |
| Total Assets | $42.2M | +6.4% | +34.0% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $8.0M | — | — |
| Capital Expenditures | $2.2M | — | — |
| Investing Cash Flow | -$2.2M | — | — |
| Financing Cash Flow | -$86K | — | — |
| Free Cash Flow | $5.8M | — | — |
| +16.4% |
| -22.0% |
| EPS (Diluted) | $0.63 | +18.9% | -22.2% |
| $5.1M |
| +8.0% |
| -4.3% |
| Total Liabilities | $5.2M | +7.0% | -1.4% |
| Stockholders' Equity | $37.0M | +6.3% | +41.2% |